$0.64
Our top picks for where to buy Onconova Therapeutics stock
How to buy Onconova Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ONTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Onconova Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Onconova Therapeutics is a biotechnology business based in the US. Onconova Therapeutics shares (ONTX) are listed on the NASDAQ and all prices are listed in US Dollars. Onconova Therapeutics employs 16 staff and has a trailing 12-month revenue of around $226,000.
Onconova Therapeutics stock price (NASDAQ: ONTX)
Use our graph to track the performance of ONTX stocks over time.Onconova Therapeutics shares at a glance
Latest market close | $7.93 |
---|---|
52-week range | $0.55 - $7.97 |
50-day moving average | $0.82 |
200-day moving average | $0.78 |
Wall St. target price | $8.33 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.96 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Onconova Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Onconova Therapeutics price performance over time
Historical closes compared with the close of $7.93 from 2024-04-03
1 week (2024-07-15) | N/A |
---|---|
1 month (2024-06-22) | N/A |
3 months (2024-04-22) | N/A |
6 months (2024-01-26) | 1,022.12% |
1 year (2023-07-26) | 685.15% |
---|---|
2 years (2022-07-26) | 589.57% |
3 years (2021-07-26) | 51.63% |
5 years (2019-07-26) | 39.45 |
Onconova Therapeutics financials
Revenue TTM | $226,000 |
---|---|
Gross profit TTM | $226,000 |
Return on assets TTM | -38.07% |
Return on equity TTM | -84.3% |
Profit margin | 0% |
Book value | $0.69 |
Market Capitalization | $20.9 million |
TTM: trailing 12 months
Onconova Therapeutics share dividends
We're not expecting Onconova Therapeutics to pay a dividend over the next 12 months.
Have Onconova Therapeutics's shares ever split?
Onconova Therapeutics's shares were split on a 1:15 basis on 20 May 2021. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Onconova Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Onconova Therapeutics shares which in turn could have impacted Onconova Therapeutics's share price.
Onconova Therapeutics share price volatility
Over the last 12 months, Onconova Therapeutics's shares have ranged in value from as little as $0.5509 up to $7.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Onconova Therapeutics's is 1.349. This would suggest that Onconova Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Onconova Therapeutics overview
Onconova Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. It has two clinical-stage programs, including narazaciclib, a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa study for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company also conducting a Phase II investigator-initiated study with rigosertib monotherapy in patients with advanced/metastatic squamous cell carcinoma associated with recessive dystrophic epidermolysis bullosa. It has a license and collaboration agreement with HanX Biopharmaceuticals, Inc. for the development, registration, and commercialization of narazaciclib in China. Onconova Therapeutics, Inc.
Frequently asked questions
What percentage of Onconova Therapeutics is owned by insiders or institutions?Currently 0.779% of Onconova Therapeutics shares are held by insiders and 7.949% by institutions. How many people work for Onconova Therapeutics?
Latest data suggests 16 work at Onconova Therapeutics. When does the fiscal year end for Onconova Therapeutics?
Onconova Therapeutics's fiscal year ends in December. Where is Onconova Therapeutics based?
Onconova Therapeutics's address is: 12 Penns Trail, Newtown, PA, United States, 18940 What is Onconova Therapeutics's ISIN number?
Onconova Therapeutics's international securities identification number is: US68232V8019 What is Onconova Therapeutics's CUSIP number?
Onconova Therapeutics's Committee on Uniform Securities Identification Procedures number is: 68232V405
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question